TY  - CONF

T1  - Meta-analysis of effects of zoledronic acid (ZOL) on survival in patients with metastatic bone disease (MBD) and high bone turnover

JO  - CANCER TREATMENT REVIEWS

PY  - 2008/01/01

AU  - Coleman R

AU  - Cook R

AU  - Saad F

AU  - Hirsh V

AU  - Major P

AU  - Dias R

AU  - Lipton A

ED  - 

DO  - DOI: 10.1016/j.ctrv.2008.03.120

VL  - 34

SP  - S86

EP  - S86

Y2  - 2025/10/10

ER  -